Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05089771 Alone and with Pregabalin on Evoked Pain in Healthy Volunteers
NCT02349607Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jan 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PF-05089771 in pain and neuropathic pain (5 arms), sponsored by Pfizer. Primary endpoints: Thermal pain detection threshold, Ultra-violet light sensitized pain detection threshold and 3 more. Started Jan 2015; status: completed.
02
Drugs
PF-05089771
03
Conditions
painneuropathic pain
Beyond the preview
Go deeper on NCT02349607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349607.